Psychotherapy Case Presentation Award
Deadline: Monday, May 21, 2012 | Learn More
Currently enrolled graduate students, residents, and
interns as well as those who have graduated with a terminal
degree after May 2010, are invited to submit a case
write-up (20-25 pages) that depicts a treatment that has
been ongoing for at least four months.
Learn More: http://tinyurl.com/7lg6oc6
William Alanson White Psychoanalytic Society
The Freud/Jung Letters: A Dramatic Reading
Friday, March 23, 2012
Moderator: Louise DeCosta, Ph.D., L.C.S.W.
Presenters: Margaret Klenck, M.Div, L.P.; Elliot Adler,
Ph.D., ABPP; William Baker, Psy.D.; Allison F. Avery, M.A.
Learn More: http://tinyurl.com/74hq2rf
Psychoanalytic Training Program
Clinical Open House
Dreams of Psychoanalysis
Monday, March 26, 2012 7:15 PM
Speaker: Mark Blechner, Ph.D.
Contributor: Helen Fronshtein, Psy.D.
Learn More: http://tinyurl.com/72mzfws
William Alanson White Psychoanalytic Society*
Social Cognitive Neuroscience Research as a Basis for
a Theory of Psychodynamic Change
Wednesday, March 28, 2012 8:00 PM
Speaker: Andrew Gerber, M.D., Ph.D.
Moderator: Pasqual J. Pantone, Ph.D.
Learn More: http://tinyurl.com/8xc5pwa
CONTINUING EDUCATION CREDIT:
* The William Alanson White Institute is accredited by
the Accreditation Council for Continuing Medical
Education to sponsor Continuing Medical Education
for Physicians. The William Alanson White Institute
designates these continuing medical education
activities for Category 1 of the Physician’s Recognition
Award of the American Medical Association. The
William Alanson White Institute is approved by the
American Psychological Association to sponsor
Continuing Education for Psychologists. The
William Alanson White Institute maintains
responsibility for these programs and their contents.
CE credits are calculated on a credit per course hour basis.
The “Conflict of Interest Policy” of the William Alanson
White Institute requires that faculty participating in CE
(and CME) activities disclose to the audience any
relationship with a pharmaceutical company, or any
real or apparent conflicts relating to the topics of any
educational activity which might pose potential,
apparent, or real conflict of interest with regard to
his or her contribution to the program.